Description
Get Access to Cerliponase alfa for Injection in India
Brineura is a medicine for treating neuronal ceroid lipofuscinosis type 2 (CLN2 disease), an inherited condition in children that leads to progressive brain damage.
What is the Generic Name for the trade name drug BRINEURA® ?
Cerliponase alfa is Generic Name for the trade name drug BRINEURA®
What is the Manufacturer Name of BRINEURA®?
BRINEURA® is manufactured by BioMarin Pharmaceutical Inc.
Is BRINEURA® approved by FDA?
Yes, BRINEURA® is approved by FDA. Date of approval: 2017
What is the dosage and form of BRINEURA® is available?
BRINEURA® is available as Injection (2 vials of 150 mg/5 mL)
What is the Highlights of prescribing information of BRINEURA®?
Click Here to download full prescribing information.





